You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Drugs Containing Excipient (Inactive Ingredient) ACID YELLOW 23


✉ Email this page to a colleague

« Back to Dashboard


Market Dynamics and Financial Trajectory for Acid Yellow 23 in Pharmaceutical Excipients

Last updated: March 20, 2026

What is Acid Yellow 23 and Its Role in Pharmaceuticals?

Acid Yellow 23 is a synthetic azo dye with the chemical identity of 4-[(2,4-diamino-1,3,5-triazin-6-yl)amino]-3-[(4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)azo]benzenesulfonic acid. It is primarily used as a coloring agent in pharmaceutical formulations, particularly in syrups, tablets, and capsules to enhance visual appeal and aid in product identification. The dye's stability under various pH levels and in different solvents makes it suitable as an excipient additive.

Market Size and Growth Drivers

Current Market Size

The global market for pharmaceutical dyes and pigments, including Acid Yellow 23, was valued at approximately USD 150 million in 2022. Acid Yellow 23 accounts for a small but significant share within this segment, estimated at USD 10-15 million.

Growth Drivers

  1. Increase in Pharmaceutical Production: Global pharmaceutical output grew at a 6.5% CAGR from 2018 to 2022, driven by aging populations and rising healthcare expenditure, enlarging the volume of products requiring excipients like Acid Yellow 23.

  2. Colorant Compatibility and Safety Standards: As regulatory agencies tighten guidelines, pharmaceutical manufacturers prefer dyes with established safety profiles, such as Acid Yellow 23, which complies with European Pharmacopoeia and FDA standards.

  3. Preference for Synthetic Dyes: Synthetic azo dyes continue to dominate due to their cost efficiency, stability, and vibrant color range, though concerns over certain azo compounds have led to stricter scrutiny.

  4. Emergence of Specialty Formulations: Growth in functional foods, nutraceuticals, and pediatric medicines amplifies demand for visually distinct products, indirectly supporting demand for pharmaceutical-grade dyes like Acid Yellow 23.

Market Limitations

Stringent regulations limiting the use of certain azo dyes owing to potential carcinogenicity and health concerns could hamper growth. Recent bans or restrictions on specific dyes in various countries significantly influence global supply chains.

Supply Chain and Key Players

Raw Material Suppliers

The synthesis of Acid Yellow 23 depends on aromatic amines, sulfonated phenols, and diazotized amines. Major suppliers include global chemical companies such as BASF, Clariant, and Emerald Kalama Chemical.

Manufacturing Locations

Production predominantly occurs in Asia (China, India) and Europe, with China accounting for approximately 55% of global dye manufacturing capacity.

Distribution Channels

Pharmaceutical manufacturers source from chemical distributors, regional suppliers, and direct from producers. Regulatory compliance and certification influence procurement choices.

Regulatory Environment and Its Impact

The regulatory landscape significantly impacts Acid Yellow 23's market trajectory:

  • The European Union classifies certain azo dyes as potential carcinogens, leading to restrictions on their use, especially in food and pharmaceuticals.
  • The FDA permits Acid Yellow 23 but limits its concentration and mandates labeling requirements.
  • The International Agency for Research on Cancer (IARC) classifies some azo compounds related to or similar to Acid Yellow 23 as Group 2B (possibly carcinogenic to humans), prompting cautious use.

Manufacturers must ensure compliance with regional standards, which can affect market access and pricing.

Competitive Landscape

Company Market Share in Dye Supply Key Offerings Geographical Presence Regulatory Certifications
BASF 35% Acid Yellow 23, others Worldwide EINECS, REACH, US FDA
Clariant 20% Synthetic dyes Europe, Asia USP, BP, European Pharmacopoeia
Emerald Kalama Chemical 10% Organic and inorganic dyes North America, Europe FDA, REACH

Financial Trajectory and Investment Outlook

Revenue Trends

The dye manufacturing segment is experiencing moderate growth, approximately 4-6% annually, driven by pharmaceutical needs. Acid Yellow 23's revenue contribution is expected to maintain a steady CAGR of 3-4% over the next five years, accounting for increased pharmaceutical production volumes and ongoing demand in Asia.

Cost Factors

Raw material price fluctuations, regulatory compliance costs, and environmental controls influence profitability. Synthesis processes involving aromatic amines face scrutiny due to environmental and health concerns, requiring investments in cleaner technologies.

Investment Opportunities

Companies investing in environmentally friendly manufacturing processes and obtaining regulatory approvals may command higher market premiums. The development of alternative dyes with comparable performance but fewer safety concerns offers long-term growth potential.

Risks

Regulatory restrictions, such as bans on certain azo dyes in key markets, can cause price volatility and supply chain disruptions. Additionally, negative consumer perception regarding synthetic dyes may limit future growth.

Conclusions

The market for Acid Yellow 23 as a pharmaceutical excipient is stable but constrained by regulatory and safety considerations. Growth depends on advancements in manufacturing, regulatory compliance, and application diversification. Asian manufacturers dominate supply, and regional regulations heavily influence demand patterns.


Key Takeaways

  • Acid Yellow 23 is a synthetic azo dye used to color pharmaceutical products; its market size is approximately USD 10-15 million.
  • Growth is driven by increasing pharmaceutical production, but regulatory restrictions on azo dyes pose constraints.
  • Asia, primarily China, supplies over half of the global capacity.
  • Regulations, particularly in the EU and US, influence market dynamics and product approvals.
  • The dye market's revenue growth is expected to be around 3-4% annually over the next five years, with supply chain and regulatory developments being key factors.

FAQs

  1. How does regulatory scrutiny affect Acid Yellow 23’s market?
    Restrictions on certain azo dyes due to health concerns limit its use or require reformulation, impacting demand and supply.

  2. What are the primary raw materials used in manufacturing Acid Yellow 23?
    Aromatic amines, sulfonated phenols, and diazotized amines are key starting materials.

  3. Who are the main producers of Acid Yellow 23?
    BASF, Clariant, and Emerald Kalama Chemical are leading global suppliers.

  4. What environmental considerations impact production costs?
    Strict controls on emissions and waste from synthesis processes increase manufacturing expenses.

  5. What future trends could influence Acid Yellow 23’s market?
    Development of safer, alternative dyes and advancements in green chemistry could reshape the market landscape.


References

[1] Allied Market Research. (2022). Global pharmaceutical dyes and pigments market. Retrieved from https://www.alliedmarketresearch.com
[2] European Pharmacopoeia. (2022). List of permitted dyes.
[3] U.S. Food and Drug Administration. (2022). Regulations on synthetic dyes in pharmaceuticals.
[4] IARC. (2018). Azo dyes and cancer risk. International Agency for Research on Cancer Reports.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.